
Insulin Glargin U300 (Toujeo)
Medication
- Изпраща се от Германия
Поръчка
- DHL с проследяване
- Дискретна опаковка
Накратко
Insulin Glargin U300 (Toujeo) в цифри
Ключовите стойности от нашия лексикон.
Пълна статия в лексикона- Class
- Long-acting basal insulinanalogue
- Use
- Subcutaneousonce daily, pen only
- Sizes
- 1.5ml/450iu1 size in the shop
What studies show
All 5 sources in the lexicon- Ritzel et al., Diabetes, Obesity and Metabolism, 2015
Отзиви
Какво казват клиентите
Само реални поръчки, които са включвали Insulin Glargin U300 (Toujeo).
Всички отзивиЗа Insulin Glargin U300 (Toujeo) все още няма лабораторен анализ. Гласувай за негоВсички лабораторни анализи
Знания
Всичко за Insulin Glargin U300 (Toujeo)
Подробна информация очаквайте скоро.
How does U300 differ from U100?
Only the concentration: 300 instead of 100 units per millilitre, the same compound. The smaller depot releases it more evenly. In a 36-hour clamp level and effect ran flatter over 24 hours and tight glucose control lasted a median of about 30 hours, around 5 hours longer than with U100.
Why is a regular insulin syringe dangerous?
Regular insulin syringes are calibrated for U-100. With U300 solution the same mark holds three times the amount and you cannot see it. In the FDA drug database the 300 units/ml version is only listed as a prefilled injector with 1.5 or 3 ml, not as a vial.
Is Insulin Glargine U300 approved?
Yes. Drugs@FDA lists the 300 units/ml version since 25 February 2015. ChEMBL lists the compound insulin glargine with first approval in 2000. Everything here is the state of research, not a recommendation.
What did the EDITION trials show?
Same glucose control, less hypoglycaemia at night. In EDITION 1 (807 participants) 36 instead of 46 percent had night-time hypoglycaemia. The pooled analysis of EDITION 1 to 3 with 2,496 people found 31 percent less night-time and 14 percent less around-the-clock hypoglycaemia. Severe episodes stayed rare (2.3 versus 2.6 percent).
Does U300 need more units?
Slightly. In EDITION 2 U300 needed about 10 percent more units than U100 for the same reduction of the long-term value. Weight gain was lower with U300.
Does the time of day matter?
In EDITION 4 with 549 people with type 1 diabetes the result was the same in the morning and in the evening, including hypoglycaemia. Fewer night-time episodes than with U100 were only seen there in the first eight weeks, weight gain was lower.
Свързани
Подобни продукти
Telmisartan
Медикаменти · Сърдечно-съдова система Сърдечно-съдова система
2 размера
Лабораторно тествано
Ivermectin
Медикаменти · Стомах и черен дроб Стомах и черен дроб
1 размер
Fenbendazol
Медикаменти · Стомах и черен дроб Стомах и черен дроб
1 размер
Prednisone
Медикаменти · Стомах и черен дроб Стомах и черен дроб
1 размер
Insulin Glargin U300 (Toujeo)